Valuation : Stereotaxis Inc

Market Cap 139M 120M 113M 103M 192M 13.17B 193M 1.34B 516M 6.75B 523M 512M 21.49B P/E 2026 *
-6.84x
P/E 2027 * -9.48x
Enterprise Value 139M 120M 113M 103M 192M 13.17B 193M 1.34B 516M 6.75B 523M 512M 21.49B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 3.05x
Free-Float
78.85%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 02/02/2017
Director of Finance/CFO 57 30/09/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 31/01/2005
Chairman - 02/02/2017
Director/Board Member 71 28/09/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-0.54%+24.60%+15.45% 227B
-1.60%-2.76%+3.72%-18.54% 146B
-0.85%-2.70%-21.45%+23.38% 130B
+1.81%-1.04%-55.42%-11.30% 69.27B
+0.13%-0.94%+11.07%+18.15% 51.82B
-0.97%-1.30%-18.25%-15.08% 50.45B
+0.59%-1.76%+17.17%+29.76% 42.53B
-1.01%-1.27%+33.64%+51.45% 40.22B
-1.55%+2.15%+120.58%+37.37% 32.95B
Average -0.47%-0.93%+12.85%+14.52% 87.75B
Weighted average by Cap. -0.63%-1.41%+6.61%+9.87%

Financials

2026 *2027 *
Net sales 34.33M 29.53M 27.77M 25.35M 47.41M 3.25B 47.57M 329M 127M 1.66B 129M 126M 5.3B 45.67M 39.27M 36.94M 33.72M 63.06M 4.32B 63.27M 438M 169M 2.21B 171M 168M 7.04B
Net income -20.13M -17.31M -16.29M -14.87M -27.8M -1.9B -27.89M -193M -74.64M -975M -75.61M -73.96M -3.11B -14.77M -12.7M -11.94M -10.9M -20.39M -1.4B -20.46M -142M -54.74M -715M -55.45M -54.24M -2.28B
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!